<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1024-0675</journal-id>
<journal-title><![CDATA[Revista de la Sociedad Boliviana de Pediatría]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. bol. ped.]]></abbrev-journal-title>
<issn>1024-0675</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Boliviana de Pediatría]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1024-06752008000200012</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identi&#64257;ed by the International Study of Asthma and Allergies in Childhood (ISAAC) - Phase 3]]></article-title>
<article-title xml:lang="pt"><![CDATA[Prevalência de sintomas de asma, rinite e eczema atópico entre crianças e adolescentes brasileiros identi&#64257;cados pelo International Study of Asthma and Allergies (ISAAC) - Fase 3]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Solé]]></surname>
<given-names><![CDATA[Dirceu]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Wandalsen]]></surname>
<given-names><![CDATA[Gustavo F.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Camelo-Nunes]]></surname>
<given-names><![CDATA[Inês Cristina]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Naspitz]]></surname>
<given-names><![CDATA[Charles K.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[ISAAC - Grupo Brasileiro]]></surname>
</name>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Universidade Federal de São Paulo Escola Paulista de Medicina ]]></institution>
<addr-line><![CDATA[São Paulo SP]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2008</year>
</pub-date>
<volume>47</volume>
<numero>2</numero>
<fpage>119</fpage>
<lpage>126</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S1024-06752008000200012&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S1024-06752008000200012&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S1024-06752008000200012&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Objetivo: Determinar a prevalência de sintomas relacionados à asma, rinite e eczema atópico em escolares (EC) entre 6 e 7 anos e adolescentes (AD) entre 13 e 14 anos, residentes em 20 cidades brasileiras, empregando o questionário escrito padronizado do ISAAC, e avaliar a sua associação com a latitude, altitude e temperatura média anual dos centros de residência. Métodos: Participaram do estudo EC e AD das cinco regiões do Brasil, totalizando 23.422 questionários ISAAC respondidos pelos pais de EC e 58.144 pelos próprios AD. Os índices de latitude, altitude e temperatura média anual foram obtidos do Instituto Brasileiro de Geogra&#64257;a e Estatística. Resultados: As prevalências médias para os EC e AD, respectivamente, foram: asma ativa, 24,3 e 19,0%; rinoconjuntivite, 12,6 e 14,6%; e eczema &#64258;exural, 8,2 e 5,0%. Associação signi&#64257;cante e negativa foi observada entre latitude e prevalência de asma diagnosticada por médico para os EC, asma grave, asma diagnosticada por médico, eczema e eczema &#64258; exural para os AD. Não houve associação com a altitude dos centros. Conclusões: A prevalência de asma, rinite e eczema ató-pico no Brasil foi variável. Valores mais altos, sobretudo de asma e eczema, foram observados nos centros localizados mais próximos ao Equador.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Objective: To determine the prevalence of symptoms of asthma, rhinitis, and atopic eczema among schoolchildren aged 6 to 7 years and adolescents aged 13 to 14 years in 20 Brazilian cities by using the standardized ISAAC written questionnaire, and to assess the association of this prevalence with latitude, altitude and average annual temperature of collaborating centers. Methods: Schoolchildren and adolescents from &#64257; ve Brazilian regions participated in the study, totaling 23,422 ISAAC questionnaires answered by schoolchildren&#8217;s parents and 58,144 questionnaires answered by adolescents. The values for latitude, altitude and average annual temperature were obtained from the Brazilian Institute of Geography and Statistics. Results: The mean prevalence rates among schoolchildren and adolescents were respectively 24.3 and 19.0% for active asthma; 12.6 and 14.6% for rhinoconjunctivitis; and 8.2 and 5.0% for atopic eczema. A signi&#64257;cant negative association was observed between latitude and physician-diagnosed asthma among schoolchildren, severe asthma, physician-diagnosed asthma, eczema and atopic eczema among adolescents. No association with altitude was found. Conclusions: The prevalence of asthma, rhinitis and atopic eczema in Brazil varies considerably. Higher prevalence rates, especially of asthma and eczema, were found at centers located closer to the equator.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Rev Soc Bol Ped 2008]]></kwd>
<kwd lng="pt"><![CDATA[47 (2): 119-26]]></kwd>
<kwd lng="pt"><![CDATA[Crianças]]></kwd>
<kwd lng="pt"><![CDATA[asma]]></kwd>
<kwd lng="pt"><![CDATA[eczema atópico]]></kwd>
<kwd lng="pt"><![CDATA[rinite]]></kwd>
<kwd lng="pt"><![CDATA[rinoconjuntivite alérgica]]></kwd>
<kwd lng="pt"><![CDATA[prevalência]]></kwd>
<kwd lng="pt"><![CDATA[ISAAC]]></kwd>
<kwd lng="pt"><![CDATA[epidemiologia]]></kwd>
<kwd lng="en"><![CDATA[Rev Soc Bol Ped 2008]]></kwd>
<kwd lng="en"><![CDATA[47 (2): 119-26]]></kwd>
<kwd lng="en"><![CDATA[Children]]></kwd>
<kwd lng="en"><![CDATA[asthma]]></kwd>
<kwd lng="en"><![CDATA[atopic eczema]]></kwd>
<kwd lng="en"><![CDATA[rhinitis]]></kwd>
<kwd lng="en"><![CDATA[allergic rhinoconjunctivitis]]></kwd>
<kwd lng="en"><![CDATA[prevalence]]></kwd>
<kwd lng="en"><![CDATA[ISAAC]]></kwd>
<kwd lng="en"><![CDATA[epidemiology]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <P align="right"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> <b>ARTICULOS DEL CONO SUR - BRASIL  </b></font></P>     <p align="justify"><b><font size="4" face="Verdana, Arial, Helvetica, sans-serif">Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identi&#64257; ed by the International Study of Asthma and Allergies in Childhood (ISAAC) - Phase 3 </font></b></p>     <p align="justify"><font size="3"><i><b><font face="Verdana, Arial, Helvetica, sans-serif">Preval&ecirc;ncia de sintomas de asma, rinite e eczema at&oacute;pico entre crian&ccedil;as e adolescentes brasileiros identi&#64257;cados pelo International Study of Asthma and Allergies (ISAAC) - Fase 3 </font></b></i></font></p>     <p align="justify"><b><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Dirceu Sol&eacute;<Sup>1</Sup>, Gustavo F. Wandalsen<Sup>2</Sup>, In&ecirc;s Cristina Camelo-Nunes<Sup>3</Sup>, Charles K. Naspitz<Sup>1</Sup>;  ISAAC - Grupo Brasileiro<Sup>4 </Sup></font></b></p>     <p><font size="1" face="Verdana, Arial, Helvetica, sans-serif">1. Professor titular, Universidade Federal de S&atilde;o Paulo &ndash; Escola Paulista de Medicina (UNIFESP-EPM), S&atilde;o Paulo, SP.    <br>   2. Mestre, UNIFESP-EPM, S&atilde;o Paulo, SP.    <br>   3. Doutora, Pesquisadora Associada, UNIFESP-EPM, S&atilde;o Paulo, SP.     <br>   4.    ISAAC - Grupo Brasileiro: Maria Socorro Cardoso (Manaus, Amazonas); Bruno A. Paes Barreto (Bel&eacute;m, Par&aacute;); Vera Dantas (Natal, Rio Grande do Norte); Murilo Britto (Recife, Pernambuco); Almerinda R. Silva, Emanuel Sarinho (Caruaru, Pernambuco); Francisco J. Passos Soares, M&eacute;rcia Lamenha Medeiros Santos (Macei&oacute;, Alagoas); Jackeline Motta, Ricardo Gurgel (Aracaju, Sergipe); Leda Solano de Freitas (Feira de Santana, Salvador e Vit&oacute;ria da Conquista, Bahia); Wellington Borges (Bras&iacute;lia, Distrito Federal); Paulo Augusto Camargos (Belo Horizonte, Minas Gerais); F&aacute;bio Kuschnir, Ant&ocirc;nio Jos&eacute; Ledo Alves da Cunha (Nova Igua&ccedil;u, Rio de Janeiro); Ant&ocirc;nio Carlos Pastorino (S&atilde;o Paulo &ndash; Oeste, S&atilde;o Paulo); Karyn Chacon de Mello (S&atilde;o Paulo &ndash; Sul, S&atilde;o Paulo); Cassia Gonzalez, Neusa F. Wandalsen (Santo Andr&eacute;, S&atilde;o Paulo); Carlos Riedi, Nelson A. Ros&aacute;rio Filho (Curitiba, Paran&aacute;); Cl&aacute;udia Benhardt (Itaja&iacute;, Santa Catarina); Arnaldo Porto (Passo Fundo, Rio Grande do Sul); Gilberto B. Fischer (Porto Alegre, Rio Grande do Sul); Vitor E. Cassol (Santa Maria, Rio Grande do Sul). </font> </p>     <P align="justify"><font size="1" face="Verdana, Arial, Helvetica, sans-serif"> <b>(1) Art&iacute;culo Original de Brasil, publicado en Jornal de Pediatria (Rio J.): 2006; 82: 341-6 y que fue seleccionado para su reproducci&oacute;n en la XII Reuni&oacute;n de Editores de Revistas Pedi&aacute;tricas del Cono Sur. Bolivia 2007. </b></font></P> <hr> <b><font size="2" face="Verdana, Arial, Helvetica, sans-serif">  Resumo  </font></b>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> <b>Objetivo:</b> Determinar a preval&ecirc;ncia de sintomas relacionados &agrave; asma, rinite e eczema at&oacute;pico em escolares (EC) entre 6 e 7 anos e adolescentes (AD) entre 13 e 14 anos, residentes em 20 cidades brasileiras, empregando o question&aacute;rio escrito padronizado do ISAAC, e avaliar a sua associa&ccedil;&atilde;o com a latitude, altitude e temperatura m&eacute;dia anual dos centros de resid&ecirc;ncia. </font></P>     ]]></body>
<body><![CDATA[<P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> <b>M&eacute;todos:</b> Participaram do estudo EC e AD das cinco regi&otilde;es do Brasil, totalizando 23.422 question&aacute;rios ISAAC respondidos pelos pais de EC e 58.144 pelos pr&oacute;prios AD. Os &iacute;ndices de latitude, altitude e temperatura m&eacute;dia anual foram obtidos do Instituto Brasileiro de Geogra&#64257;a e Estat&iacute;stica. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> <b>Resultados:</b> As preval&ecirc;ncias m&eacute;dias para os EC e AD, respectivamente, foram: asma ativa, 24,3 e 19,0%; rinoconjuntivite, 12,6 e 14,6%; e eczema &#64258;exural, 8,2 e 5,0%. Associa&ccedil;&atilde;o signi&#64257;cante e negativa foi observada entre latitude e preval&ecirc;ncia de asma diagnosticada por m&eacute;dico para os EC, asma grave, asma diagnosticada por m&eacute;dico, eczema e eczema &#64258; exural para os AD. N&atilde;o houve associa&ccedil;&atilde;o com a altitude dos centros. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> <b>Conclus&otilde;es:</b> A preval&ecirc;ncia de asma, rinite e eczema at&oacute;-pico no Brasil foi vari&aacute;vel. Valores mais altos, sobretudo de asma e eczema, foram observados nos centros localizados mais pr&oacute;ximos ao Equador. </font></P> <font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Palabras clave:</b>  </font>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Rev Soc Bol Ped 2008; 47 (2): 119-26: Crian&ccedil;as, asma, eczema at&oacute;pico, rinite, rinoconjuntivite al&eacute;rgica, preval&ecirc;ncia, ISAAC, epidemiologia. </font></P> <hr> <b><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Abstract  </font></b>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> <b>Objective:</b> To determine the prevalence of symptoms of asthma, rhinitis, and atopic eczema among schoolchildren aged 6 to 7 years and adolescents aged 13 to 14 years in 20 Brazilian cities by using the standardized ISAAC written questionnaire, and to assess the association of this prevalence with latitude, altitude and average annual temperature of collaborating centers. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> <b>Methods:</b> Schoolchildren and adolescents from &#64257; ve Brazilian regions participated in the study, totaling 23,422 ISAAC questionnaires answered by schoolchildren&rsquo;s parents and 58,144 questionnaires answered by adolescents. The values for latitude, altitude and average annual temperature were obtained from the Brazilian Institute of Geography and Statistics. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> <b>Results:</b> The mean prevalence rates among schoolchildren and adolescents were respectively 24.3 and 19.0% for active asthma; 12.6 and 14.6% for rhinoconjunctivitis; and 8.2 and 5.0% for atopic eczema. A signi&#64257;cant negative association was observed between latitude and physician-diagnosed asthma among schoolchildren, severe asthma, physician-diagnosed asthma, eczema and atopic eczema among adolescents. No association with altitude was found. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> <b>Conclusions:</b> The prevalence of asthma, rhinitis and atopic eczema in Brazil varies considerably. Higher prevalence rates, especially of asthma and eczema, were found at centers located closer to the equator. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> <b>Key words: </b></font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Rev Soc Bol Ped 2008; 47 (2): 119-26: Children, asthma, atopic eczema, rhinitis, allergic rhinoconjunctivitis, prevalence, ISAAC, epidemiology. </font></P> <DL class="unexpected-ListItem">   <hr> </dl>     ]]></body>
<body><![CDATA[<p><font size="3"><b> <font face="Verdana, Arial, Helvetica, sans-serif">Introdu&ccedil;&atilde;o </font> </b></font></p>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> <i>O International Study of Asthma and Allergies in Childhood</i> (ISAAC) foi um marco importante entre os estudos epidemiol&oacute;gicos sobre preval&ecirc;ncia de asma e doen&ccedil;as al&eacute;rgicas em crian&ccedil;as e adolescentes. O ISAAC foi idealizado para avaliar a preval&ecirc;ncia de asma e doen&ccedil;as al&eacute;rgicas em crian&ccedil;as em diferentes partes do mundo, empregando m&eacute;todo padronizado (question&aacute;rio escrito auto-aplic&aacute;vel e/ou v&iacute;deo question&aacute;rio)<sup>1,2</sup>. O question&aacute;rio escrito (QE) auto-aplic&aacute;vel do ISAAC foi o instrumento mais empregado, por ser de f&aacute;cil compreens&atilde;o, baixo custo e independente da aplica&ccedil;&atilde;o por entrevistador treinado<Sup>1,2</Sup>. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> A popula&ccedil;&atilde;o-alvo deveria ser constitu&iacute;da por escolares (EC) dentro de determinada &aacute;rea geogr&aacute;&#64257;ca (centro do ISAAC) de duas faixas et&aacute;rias: 13 a 14 anos e 6 a 7 anos. A participa&ccedil;&atilde;o de EC na faixa et&aacute;ria dos 6 aos 7 anos, embora recomendada, n&atilde;o era compuls&oacute;ria. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> A amostra em estudo deveria incluir todas as crian&ccedil;as da faixa et&aacute;ria em estudo, de uma amostra randomizada de escolas. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Uma vez de&#64257;nida a &aacute;rea geogr&aacute;&#64257;ca e as escolas a serem inclu&iacute;das, cada centro de investiga&ccedil;&atilde;o deveria selecionar, com base nos registros escolares, adolescentes (AD) com idades entre 13 e 14 anos, os quais seriam convidados a responder o QE. A sele&ccedil;&atilde;o do grupo adicional de 6 a 7 anos seguiria os mesmos crit&eacute;rios, e os pais dessas crian&ccedil;as seriam convidados a responder o QE. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Na primeira fase do ISAAC, foram entrevistados 463.801 AD (13 e 14 anos) oriundos de 155 centros de 56 pa&iacute;ses (Europa, &Aacute;sia, &Aacute;frica, Am&eacute;ricas do Norte e Sul e Oceania) bem como 257.800 EC (6 e 7 anos) de 91 centros de 38 pa&iacute;ses das mesmas regi&otilde;es, exceto a &Aacute;frica<Sup>2-5</Sup>. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> A an&aacute;lise dos resultados obtidos ao &#64257;nal da fase 1, referentes &agrave; asma, mostrou ter havido ampla varia&ccedil;&atilde;o, nas duas faixas et&aacute;rias, com rela&ccedil;&atilde;o &agrave; preval&ecirc;ncia de sibilos nos &uacute;ltimos 12 meses (asma ativa), variando de 4,1 a 32,1% para os EC e de 2,1 a 32,2% para os AD2,3. Os valores mais baixos foram documentados na Rep&uacute;blica da Ge&oacute;rgia e Est&ocirc;nia, e os mais elevados, na Austr&aacute;lia<Sup>2,3</Sup>. Em ambas as faixas et&aacute;rias, o Brasil &#64257;cou entre os pa&iacute;ses com maiores preval&ecirc;ncias<Sup>3,6</Sup>. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Com rela&ccedil;&atilde;o &agrave; rinite, a varia&ccedil;&atilde;o na preval&ecirc;ncia de sintomas relacionados tamb&eacute;m foi ampla<Sup>4</Sup>. A preval&ecirc;ncia de sintomas nasais na aus&ecirc;ncia de resfriados no &uacute;ltimo ano variou de 1,5 a 41,8% entre os EC e de 3,2 a 66,6% entre os AD4. J&aacute; a preval&ecirc;ncia de sintomas nasais associados a sintomas oculares (rinoconjuntivite al&eacute;rgica) variou de 0,8 a 14,9% para os EC e de 1,4 a 39,7% para os AD4. De modo geral, houve concord&acirc;ncia entre as preval&ecirc;ncias de asma e de rinite: centros com baixa preval&ecirc;ncia de asma (inferior a 5%: Indon&eacute;sia, Alb&acirc;nia, Rom&ecirc;nia, Ge&oacute;rgia e Gr&eacute;cia) tiveram baixa preval&ecirc;ncia de rinite, e aqueles com preval &ecirc;ncia de asma muito elevada (superior a 30%: Austr&aacute;lia, Nova Zel&acirc;ndia, e Reino Unido) tamb&eacute;m apresentaram alta preval&ecirc;ncia de rinite<Sup>3,4</Sup>. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Os resultados sobre eczema at&oacute;pico (EA) foram os que apresentaram maior amplitude de varia&ccedil;&atilde;o (at&eacute; 60 vezes), oscilando entre 0,3 e 20,5%2,5. Os valores mais altos (acima de 15%) foram observados em centros urbanos da &Aacute;frica, Austr&aacute;lia, Norte e Oeste da Europa, e os mais baixos (inferiores a 5%) na China, Leste Europeu e &Aacute;sia Central<Sup>2,5</Sup>. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> A partir da obten&ccedil;&atilde;o desses dados, v&aacute;rios outros estudos foram realizados com o intuito de veri&#64257; car a rela&ccedil;&atilde;o entre a preval&ecirc;ncia de asma e das doen&ccedil;as al&eacute;rgicas e poss&iacute;veis fatores de risco. A imuniza&ccedil;&atilde;o de rotina<Sup>7</Sup>, as noti&#64257;ca&ccedil;&otilde;es de tuberculose<Sup>8,9</Sup> e o padr&atilde;o alimentar<Sup>10</Sup> foram alguns dos fatores estudados. Em estudo recente, Weiland et al. avaliaram a poss&iacute;vel rela&ccedil;&atilde;o entre latitude, umidade relativa do ar e varia&ccedil;&atilde;o anual da temperatura dos centros participantes do ISAAC fase 1 e a preval&ecirc;ncia de asma e de doen&ccedil;as al&eacute;rgicas<sup>11</sup>. Veri&#64257;caram rela&ccedil;&atilde;o negativa entre esses par&acirc;metros e a preval&ecirc;ncia de sintomas de asma. Por outro lado, a preval&ecirc;ncia de sintomas de eczema relacionou-se positivamente com a latitude e negativamente com a temperatura m&eacute;dia ambiental, ou seja, locais com menores varia&ccedil;&otilde;es de temperatura foram associados a maiores n&iacute;veis de preval&ecirc;ncia<Sup>11</Sup>. Em conclus&atilde;o, esses autores apontam que o clima &eacute; um fator importante e capaz de interferir na preval&ecirc;ncia de asma e EA<Sup>11</Sup>. </font></P>     ]]></body>
<body><![CDATA[<P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Na Am&eacute;rica Latina, ao &#64257;nal da primeira fase do ISAAC, Mallol et al. documentaram rela&ccedil;&atilde;o signi&#64257;cante entre preval&ecirc;ncia e gravidade da asma e a latitude dos centros participantes avaliados<Sup>12</Sup>. Alguns desses centros eram brasileiros. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> O n&uacute;mero reduzido de centros brasileiros participantes da fase 1, aliado &agrave; aus&ecirc;ncia de centros em algumas regi&otilde;es do pa&iacute;s, impediu a realiza&ccedil;&atilde;o dessa avalia&ccedil;&atilde;o<Sup>6,13,14</Sup>. Este estudo teve por objetivo avaliar a rela&ccedil;&atilde;o entre preval&ecirc;ncia de sintomas de asma, rinite e eczema e a latitude dos diferentes centros brasileiros participantes ou n&atilde;o do ISAAC fase 3. </font></P> <b><font size="3" face="Verdana, Arial, Helvetica, sans-serif">    <br> Casu&iacute;stica e m&eacute;todos </font> </b>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Vinte e um centros de 20 cidades brasileiras participaram deste estudo. Os alunos avaliados foram selecionados conforme o preconizado pelo protocolo ISAAC<Sup>1,15</Sup>. Em cada centro, uma vez estipulada a &aacute;rea geogr&aacute;&#64257;ca em que o estudo seria conduzido, solicitou-se &agrave; Secretaria Municipal de Educa&ccedil;&atilde;o a rela&ccedil;&atilde;o das escolas nela localizadas. A seguir, procedeu-se sorteio (tabela de n&uacute;meros aleat&oacute;rios) das que participariam do estudo. As cidades, estados e regi&otilde;es onde o estudo foi realizado foram os seguintes: Manaus, Amazonas, Norte (N); Bel&eacute;m, Par&aacute;, N; Natal, Rio Grande do Norte, Nordeste (NE); Recife, Pernambuco, NE; Caruaru, Pernambuco, NE; Macei&oacute;, Alagoas, NE; Aracaju, Sergipe, NE; Feira de Santana, Bahia, NE; Salvador, Bahia, NE; Vit&oacute;ria da Conquista, Bahia, NE; Bras&iacute;lia, Distrito Federal, Cento-Oeste (CO); Belo Horizonte, Minas Gerais, Sudeste (SE); Nova Igua&ccedil;u, Rio de Janeiro, SE; S&atilde;o Paulo (Oeste e Sul), S&atilde;o Paulo, SE; Santo Andr&eacute;, S&atilde;o Paulo, SE; Curitiba, Paran&aacute;, Sul (S); Itaja&iacute;, Santa Catarina, S; Passo Fundo, Rio Grande do Sul, S; Porto Alegre, Rio Grande do Sul, S; Santa Maria, Rio Grande do Sul, S. Parte desses centros tiveram os dados aprovados pelo ISAAC International Data Center e foram considerados como centros o&#64257;ciais (<a href="#t1">Tabelas 1</a> e <a href="#t2">2</a>). O estudo foi aprovado pelos respectivos comit&ecirc;s de &eacute;tica, e todos assinaram o termo de consentimento livre e esclarecido. </font></P>     <P align="center"><a name="t1"></a><a href="/img/revistas/rbp/v47n2/tabla12_1.gif"><img src="/img/revistas/rbp/v47n2/tabla12_1_.gif" width="222" height="178" border="0"></a></P>     <P align="center">&nbsp;</P>     <P align="center"><a name="t2"></a><a href="/img/revistas/rbp/v47n2/tabla12_2.gif"><img src="/img/revistas/rbp/v47n2/tabla12_2_.gif" width="222" height="225" border="0"></a></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Optaram por n&atilde;o avaliar a faixa et&aacute;ria dos 6 aos 7 anos (n&atilde;o compuls&oacute;ria) os seguintes centros: Bel&eacute;m, Recife, Caruaru, Bras&iacute;lia, Belo Horizonte, Curitiba, Passo Fundo, Porto Alegre e Santa Maria. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> O estudo teve in&iacute;cio em 2002 e foi conclu&iacute;do em 2003, conforme recomenda&ccedil;&atilde;o do ISAAC, obedecendo, quando poss&iacute;vel, o mesmo per&iacute;odo de coleta dos dados em todos os centros. Na Regi&atilde;o Sul, onde as esta&ccedil;&otilde;es s&atilde;o mais bem de&#64257;nidas, foi realizado antes da primavera, evitando-se assim poss&iacute;veis in&#64258; u&ecirc;ncias sazonais. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Ap&oacute;s a de&#64257;ni&ccedil;&atilde;o da amostra, em cada uma das cidades, o QE ISAAC, previamente traduzido e validado (cultura brasileira)<Sup>14,16,17</Sup>, foi respondido pelos pais ou respons&aacute;-veis dos EC de 6 e 7 anos de idade (n = 23.422) e pelos pr&oacute;prios AD nas salas de aula (n = 58.144, 13-14 anos de idade). Os dados obtidos foram transcritos manualmente para banco de dados fornecido pelos coordenadores gerais do protocolo ISAAC. </font></P>     ]]></body>
<body><![CDATA[<P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Do m&oacute;dulo asma, foram consideradas as quest&otilde;es sobre sintomas, gravidade e diagn&oacute;stico m&eacute;dico de asma, a saber: sibilos nos &uacute;ltimos 12 meses (asma ativa); sibilos intensos capazes de limitarem a fala nos &uacute;ltimos 12 meses (asma grave); asma alguma vez na vida (asma diagnosticada)<Sup>1,3</Sup>. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Do m&oacute;dulo rinite, foram consideradas as quest&otilde;es referentes a sintomas de rinite, rinoconjuntivite al&eacute;rgica e de formas graves de rinite: espirros, coriza e obstru&ccedil;&atilde;o nasal alguma vez nos &uacute;ltimos 12 meses (rinite); problemas nasais associados a olhos com prurido e lacrimejamento nos &uacute;ltimos 12 meses (rinoconjuntivite al&eacute;rgica); problema nasal interferindo com atividade di&aacute;ria (rinite grave)<Sup>1,4</Sup>. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Das quest&otilde;es sobre eczema, foram avaliadas as referentes a sintomas e gravidade: rash cut&acirc;neo que aparece e desaparece nos &uacute;ltimos 12 meses (eczema); este mesmo rash cut&acirc;neo em locais caracter&iacute;sticos (eczema &#64258;exural); rash cut&acirc;neo e pruriginoso que interfere com o sono nos &uacute;ltimos 12 meses (eczema grave)<Sup>1,5</Sup>. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Os valores de latitude, altitude e temperatura m&eacute;dia anual de cada um dos centros participantes foram obtidos junto ao Instituto Brasileiro de Geogra&#64257; a e Estat&iacute;stica<Sup>18</Sup>. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Para an&aacute;lise dos dados, foram empregados testes n&atilde;oparam &eacute;tricos: coe&#64257;ciente de correla&ccedil;&atilde;o de Spearman (RS) e o c&aacute;lculo do intervalo de con&#64257;an&ccedil;a de 95% (IC95%). Em todos os testes, &#64257; xou-se em 5% o n&iacute;vel de rejei&ccedil;&atilde;o para a hip&oacute;tese de nulidade. </font></P> <b><font size="3" face="Verdana, Arial, Helvetica, sans-serif">    <br> Resultados  </font></b><font face="Verdana, Arial, Helvetica, sans-serif">     <P align="justify"><font size="2"> Entre os EC, as preval&ecirc;ncias m&eacute;dias foram: asma ativa, 24,3%, com valores mais elevados em S&atilde;o Paulo - Oeste e Vit&oacute;ria da Conquista; asma grave, 6,1%, e os valores mais elevados em S&atilde;o Paulo</font><font size="2">-Oeste e Natal; asma diagnosticada por m&eacute;dico, 10,3% (Manaus e Natal); rinite, 25,7% (Bahia, Feira de Santana, Salvador e Vit&oacute;ria da Conquista); rinoconjuntivite, 12,6% (Bahia); rinite grave, 17,1% (Bahia); eczema, 11,5% (Nova Igua&ccedil;u, Natal e Aracaju); eczema &#64258;exural, 8,2% (Natal, Aracaju e Nova Igua&ccedil;u); e eczema grave, 5,0% (Natal e Aracaju) (<a href="#t1">Tabela 1</a>). </font></P>     <P align="justify"><font size="2"> Entre os AD, as preval&ecirc;ncias m&eacute;dias foram: asma ativa, 19,0%, com valores mais elevados em Salvador e Vit&oacute;ria da Conquista; asma grave, 4,7%, </font><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> com valores mais elevados em Vit&oacute;ria da Conquista e Aracaju; asma diagnosticada por m&eacute;dico, 13,6% (Bel&eacute;m, Porto Alegre e Caruaru); rinite, 29,6% (Bel&eacute;m, Salvador e Vit&oacute;ria da Conquista); rinoconjuntivite al&eacute;rgica, 14,6% (Bel&eacute;m, Salvador e Vit&oacute;ria da Conquista); rinite grave, 17,4% (Bahia); eczema, 8,9% (Bel&eacute;m, Aracaju e Salvador); eczema &#64258;exural, 5,0% (Aracaju, Vit&oacute;ria da Conquista e Natal); e eczema grave, 4,4% (Bahia e Aracaju) (<a href="#t2">Tabela 2</a>). </font></P> </font>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> O estudo da associa&ccedil;&atilde;o entre a latitude dos centros e a preval&ecirc;ncia de sintomas e de gravidade de asma, rinite e EA mostrou signi&#64257;c&acirc;ncia estat&iacute;stica e negativa para asma diagnosticada por m&eacute;dico (RS = -0,622; IC95% -0,885 a - 0,056; p = 0,031) para os EC, asma grave (RS = -0,565; IC95% -0,806 a -0,163; p = 0,008), asma diagnosticada por m&eacute;dico (RS = -0,479; IC95% -0,761 a -0,046; p = 0,028), eczema (RS = -0,718; IC95% -0,881 a -0,405; p = </font><font size="2" face="Verdana, Arial, Helvetica, sans-serif">0,0002) e eczema &#64258;exural (RS = -0,530; IC95% 0,788 a -0,115; p = 0,013) para os AD. Em outras palavras, quanto menor a latitude (maior a proximidade do Equador), maior a preval&ecirc;ncia de respostas a&#64257;rmativas a essas quest&otilde;es. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Com rela&ccedil;&atilde;o &agrave; temperatura m&eacute;dia anual, houve as-socia &ccedil;&atilde;o signi&#64257;cante e positiva com o diagn&oacute;stico de asma pelo m&eacute;dico (RS = 0,459; IC95% 0,02 a 0,749; p = 0,037), assim como com eczema (RS = 0,541; IC95% 0,129 a 0,794; p = 0,011) entre os AD. Assim, quanto maior a temperatura m&eacute;dia anual, maior a preval&ecirc;ncia de diagn&oacute;stico m&eacute;dico de asma e eczema. </font></P> <b><font size="3" face="Verdana, Arial, Helvetica, sans-serif">    ]]></body>
<body><![CDATA[<br> Discuss&atilde;o </font> </b>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> As taxas de preval&ecirc;ncia de asma e doen&ccedil;as al&eacute;rgicas mais elevadas foram observadas nos centros das Regi&otilde;es Norte e Nordeste, exce&ccedil;&atilde;o feita &agrave; de asma, que tamb&eacute;m foi observada na Regi&atilde;o Sul. O aumento em tr&ecirc;s vezes do n&uacute;mero de centros participantes em rela&ccedil;&atilde;o ao ISAAC fase 1<Sup>6,13,14</Sup>, a presen&ccedil;a de centros das cinco regi&otilde;es do pa&iacute;s e o n&iacute;vel elevado de retorno dos QE distribu&iacute;dos<Sup>2,3</Sup> permitem-nos aceitar a amostra aqui avaliada como representativa do Brasil. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> O ISAAC fase 1 na Am&eacute;rica Latina concentrou dados de 17 centros de nove pa&iacute;ses e reuniu 36.264 EC e 52.549 AD. A preval&ecirc;ncia de asma e sintomas relacionados mostrou-se alta e vari&aacute;vel, como a descrita para pa&iacute;ses industrializados ou regi&otilde;es desenvolvidas do mundo<Sup>12</Sup>. A preval&ecirc;ncia de asma ativa variou entre 8,6 e 32,1% para os EC e entre 6,6 e 27,0% para os AD, e os n&iacute;veis mais elevados de preval&ecirc;ncia foram observados nos centros pr&oacute;ximos &agrave; linha do Equador. Al&eacute;m disso, n&atilde;o se documentou rela&ccedil;&atilde;o entre exposi&ccedil;&atilde;o &agrave; polui&ccedil;&atilde;o atmosf&eacute;rica, exposi&ccedil;&atilde;o precoce a infec&ccedil;&otilde;es respirat&oacute;rias e gastrointestinais e a preval&ecirc;ncia de asma<Sup>12</Sup>. Tais dados colocam em cheque a validade da hip&oacute;tese da higiene para a Am&eacute;rica Latina como um todo<Sup>12</Sup>. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Weiland et al. investigaram a rela&ccedil;&atilde;o entre o clima (latitude, amplitude de varia&ccedil;&atilde;o anual da temperatura exterior (diferen&ccedil;a entre a m&aacute;xima anual e a m&iacute;nima anual) e teor de umidade intradomiciliar) e a preval&ecirc;ncia de doen&ccedil;as at&oacute;picas utilizando os dados do ISAAC fase 1 (146 centros). Em rela&ccedil;&atilde;o aos sintomas de asma, veri&#64257;caram rela&ccedil;&atilde;o inversa entre altitude, varia&ccedil;&atilde;o anual de temperatura e umidade relativa intradomiciliar<Sup>11</Sup>. A an&aacute;lise de parte desses dados mostrou, para pa&iacute;ses do Oeste Europeu, ter havido aumento da preval&ecirc;ncia dos sintomas de asma em associa&ccedil;&atilde;o ao aumento da umidade anual intradomiciliar estimada<Sup>11</Sup>. No presente estudo, veri&#64257;camos rela&ccedil;&atilde;o signi&#64257;cante e negativa para asma diagnosticada por m&eacute;dico entre os EC e de asma diagnosticada por m&eacute;dico e de asma grave entre os AD. Esse fato poderia ser explicado por diferen&ccedil;as na conduta e denomina&ccedil;&atilde;o da doen&ccedil;a ao longo do pa&iacute;s. Entretanto, ao considerarmos a preval&ecirc;ncia de formas graves, veri&#64257;camos o mesmo comportamento para os AD. Tal fato seguramente refor&ccedil;a a maior preval&ecirc;ncia da asma ao Norte do pa&iacute;s. Esse dado &eacute; corroborado pela rela&ccedil;&atilde;o signi&#64257;cante e positiva observada entre temperatura m&eacute;dia e preval&ecirc;ncia de asma diagnosticada. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Com rela&ccedil;&atilde;o &agrave; rinite e sintomas relacionados, n&atilde;o documentamos rela&ccedil;&atilde;o signi&#64257;cante entre a sua preval&ecirc;ncia e as vari&aacute;veis analisadas para as duas faixas et&aacute;rias, &agrave; semelhan&ccedil;a de outros estudos<Sup>11</Sup>. Por outro lado, houve rela&ccedil;&atilde;o signi&#64257;cante e negativa entre a preval&ecirc;ncia de eczema e de eczema &#64258; exural e a latitude dos centros. Valores mais altos ocorreram ao Norte do pa&iacute;s, assim como de eczema em locais com maiores temperaturas m&eacute;dias. A exposi&ccedil;&atilde;o a temperaturas mais elevadas e constantes, o alto teor de umidade ambiental, a maior exposi&ccedil;&atilde;o da pele pelo uso de roupas mais leves, aliados &agrave; maior freq&uuml;&ecirc;ncia de afec&ccedil;&otilde;es dermatol&oacute;gicas nessa regi&atilde;o poderiam ser algumas das raz&otilde;es para justi&#64257; car o aumento de preval&ecirc;ncia de eczema, denomina&ccedil;&atilde;o que pode albergar v&aacute;rios quadros dermatol&oacute;gicos. Todavia, o mesmo comportamento observado com a preval&ecirc;ncia de eczema &#64258;exural, caracter&iacute;stico de EA, p&otilde;e em questionamento o apontado anteriormente. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Este acena para o calor e a umidade como fatores de risco para EA. Diferente do observado no presente estudo, Weiland et al. documentaram aumento da preval &ecirc;ncia de eczema e sintomas relacionados, em ambas as faixas et&aacute;rias, com o aumento da latitude e diminui&ccedil;&atilde;o com o aumento da amplitude da temperatura m&eacute;dia anual externa, assim como com o aumento da umidade relativa intradomiciliar do ar<Sup>11</Sup>. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Nnoruka et al., ao avaliarem crian&ccedil;as nigerianas com EA, identi&#64257;caram intoler&acirc;ncia ao calor, transpira&ccedil;&atilde;o excessiva e umidade intradomiciliar como fatores agravantes para o EA<Sup>19</Sup>, &agrave; semelhan&ccedil;a de outros<Sup>20</Sup>. J&aacute; Fern&aacute;ndez-Mayoralas et al. documentaram in&#64258;u&ecirc;ncia da polui&ccedil;&atilde;o atmosf&eacute;rica sobre a preval&ecirc;ncia de EA em adolescentes que habitavam a cidade de Cartagena (Espanha)<Sup>21</Sup>. Os autores veri&#64257;caram n&iacute;veis elevados de preval&ecirc;ncia de EA e de formas graves entre os que estavam expostos a n&iacute;veis mais elevados de polui&ccedil;&atilde;o<Sup>21</Sup>. No presente estudo, n&atilde;o observamos qualquer in&#64258;u&ecirc;ncia da polui&ccedil;&atilde;o atmosf&eacute;rica sobre a preval&ecirc;ncia de EA, sobretudo se considerarmos os centros de S&atilde;o Paulo e Santo Andr&eacute;, onde s&atilde;o tradicionalmente documentados os maiores n&iacute;veis de polui&ccedil;&atilde;o atmosf&eacute;rica do pa&iacute;s. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Em conclus&atilde;o, com o aumento do n&uacute;mero de centros participantes deste estudo no Brasil, pudemos encontrar, &agrave; semelhan&ccedil;a do observado na Am&eacute;rica Latina ao &#64257;nal da fase 1, maior freq&uuml;&ecirc;ncia de diagn&oacute;stico m&eacute;dico de asma, para EC e AD, e formas mais graves de asma, eczema e eczema &#64258;exural entre os AD habitantes de centros mais pr&oacute;ximos &agrave; linha do Equador. A identi&#64257;ca&ccedil;&atilde;o de fatores de risco aos quais os habitantes desses centros possam estar expostos &eacute; passo fundamental para a poss&iacute;vel elucida&ccedil;&atilde;o da etiopatogenia da asma e das doen&ccedil;as al&eacute;rgicas nessas localidades. </font></P> <b><font size="3" face="Verdana, Arial, Helvetica, sans-serif">    <br> Refer&ecirc;ncias </font> </b>     <!-- ref --><P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 1. 	Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J. 1995;8: 483-91. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408525&pid=S1024-0675200800020001200001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">   2. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351:1225-32. </font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">   3. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J. 1998;12:315-35. </font></p>     <!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">   4. Strachan D, Sibbald B, Weiland S, Ait-Khaled N, Anabwani G, Anderson HR, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol. 1997;8:161-76. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408528&pid=S1024-0675200800020001200004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 5. Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol. 1999;103:125-38. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408529&pid=S1024-0675200800020001200005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 6. Sol&eacute; D, Yamada E, Vanna AT, Werneck G, Solano de Freitas L, Sologuren MJ, et al. International Study of Asthma and Allergies in Childhood (ISAAC): prevalence of asthma and asthmarelated symptoms among Brazilian schoolchildren. J Invest Allergol Clin Immunol. 2001;11:123-8. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408530&pid=S1024-0675200800020001200006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">   7. Anderson HR, Poloniecki JD, Strachan DP, Beasley R, Bjorksten B, Asher MI, et al. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am J Public Health. 2001;91:1126-9. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408531&pid=S1024-0675200800020001200007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 8. Von Mutius E, Pearce N, Beasley R, Cheng S, von Ehrenstein O, Bjorksten B, et al. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax. 2000;55:449-53. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408532&pid=S1024-0675200800020001200008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 9. Shirtcliffe P, Weatherall M, Beasley R, International Study of Asthma and Allergies in Childhood. An in-verse correlation between estimated tuberculosis noti&#64257;cation rates and asthma symptoms. Respirology. 2002;7:153-5. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408533&pid=S1024-0675200800020001200009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">   10. Ellwood P, Asher MI, Bjorksten B, Burr M, Pearce N, Robertson CF. Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Respir J. 2001;17: 436-43. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408534&pid=S1024-0675200800020001200010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">   11. Weiland SK, Husing A, Strachan DP, Rzehak P, Pearce N, ISAAC Phase One Study Group. Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occup Environ Med. 2004;61:609-15. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408535&pid=S1024-0675200800020001200011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 12. Mallol J, Sol&eacute; D, Asher I, Clayton T, Stein R, Soto-Quiroz M. Prevalence of asthma symptoms in Latin America: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Pulmonol. 2000;30:439-44. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408536&pid=S1024-0675200800020001200012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 13. Sol&eacute; D, Camelo-Nunes IC, Vanna AT, Yamada E, Werneck F, de Freitas LS, et al. Prevalence of rhinitis and related-symptoms in schoolchildren from different cities in Brazil. Allergol Immunopathol (Madr). 2004;32:7-12. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408537&pid=S1024-0675200800020001200013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 14. Yamada E, Vanna AT, Naspitz CK, Sol&eacute; D. International Study of Asthma and Allergies in Childhood (ISAAC): validation of the written questionnaire (eczema component) and prevalence of atopic eczema among Brazilian children. J Investig Allergol Clin Immunol. 2002;12:34-41. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408538&pid=S1024-0675200800020001200014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">   15. Ellwood P, Asher MI, Beasley R, Clayton TO, Stewartt AW, ISAAC Steering Committee. The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis. 2005;9:10-6. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408539&pid=S1024-0675200800020001200015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 16. Sol&eacute; D, Vanna AT, Yamada E, Rizzo MC, Naspitz CK. International Study of Asthma and Allergies in Childhood (ISAAC) written questionnaire: validation of the asthma component among Brazilian children. J Invest Allergol Clin Immunol. 1998;8:376-82. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408540&pid=S1024-0675200800020001200016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 17. Vanna AT, Yamada E, Arruda LK, Naspitz CK, Sole D. International Study of Asthma and Allergies in Childhood: validation of the rhinitis symptom questionnaire and prevalence of rhinitis in schoolchildren in S&atilde;o Paulo, Brazil. Pediatr Allergy Immunol. 2001;12:95-101. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408541&pid=S1024-0675200800020001200017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 18. Instituto Brasileiro de Geogra&#64257;a e Estat&iacute;stica [site na Internet]. http://www.ibge.gov.br/home/geociencias/ geogra&#64257; a. Acesso: 20/09/2005. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408542&pid=S1024-0675200800020001200018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">   19. Nnoruka EM. Current epidemiology of atopic dermatitis in southeastern Nigeria. Int J Dermatol. 2001;43:739-44. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408543&pid=S1024-0675200800020001200019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">   20. McNally NJ, Williams HC, Phillips DR. Atopic eczema and the home environment. Br J Dermatol. 2001;145:730-6. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408544&pid=S1024-0675200800020001200020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 21. Fern&aacute;ndez-Mayoralas DM, Caballero JMM, Alvarez LGM. Prevalencia de la dermatitis at&oacute;pica en escolares de Cartagena y su relaci&oacute;n con el sexo y la contaminaci&oacute;n. An Pediatr (Barc). 2004;60:555-60. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=408545&pid=S1024-0675200800020001200021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><div align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Correspond&ecirc;ncia</b>: </font><font face="Verdana, Arial, Helvetica, sans-serif"></font></div> <font face="Verdana, Arial, Helvetica, sans-serif">     <P align="justify"><font size="2"> Dirceu Sol&eacute; Rua Mirassol 236 / 72, Vila Clementino CEP 04044-010 - S&atilde;o Paulo, SP E-mail: <a href="mailto:dirceus@ajato.com.br">dirceus@ajato.com.br</a> </font></P> </font>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Asher]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Keil]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Beasley]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Crane]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[International study of asthma and allergies in childhood (ISAAC): rationale and methods]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>1995</year>
<volume>8</volume>
<page-range>483-91</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<collab>The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee</collab>
<article-title xml:lang="en"><![CDATA[Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1998</year>
<volume>351</volume>
<page-range>1225-32</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<collab>the International Study of Asthma and Allergies in Childhood (ISAAC)</collab>
<article-title xml:lang="en"><![CDATA[Worldwide variations in the prevalence of asthma symptoms]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>1998</year>
<volume>12</volume>
<page-range>315-35</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Strachan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sibbald]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Weiland]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ait Khaled]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Anabwani]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC)]]></article-title>
<source><![CDATA[Pediatr Allergy Immunol]]></source>
<year>1997</year>
<volume>8</volume>
<page-range>161-76</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Robertson]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ait Khaled]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Anabwani]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood]]></article-title>
<source><![CDATA[J Allergy Clin Immunol]]></source>
<year>1999</year>
<volume>103</volume>
<page-range>125-38</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Solé]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Yamada]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vanna]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Werneck]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Solano de Freitas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sologuren]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[International Study of Asthma and Allergies in Childhood (ISAAC): prevalence of asthma and asthmarelated symptoms among Brazilian schoolchildren]]></article-title>
<source><![CDATA[J Invest Allergol Clin Immunol]]></source>
<year>2001</year>
<volume>11</volume>
<page-range>123-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Poloniecki]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Strachan]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Beasley]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bjorksten]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Asher]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood]]></article-title>
<source><![CDATA[Am J Public Health]]></source>
<year>2001</year>
<volume>91</volume>
<page-range>1126-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Von Mutius]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pearce]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Beasley]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cheng]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[von Ehrenstein]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Bjorksten]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema]]></article-title>
<source><![CDATA[Thorax]]></source>
<year>2000</year>
<volume>55</volume>
<page-range>449-53</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shirtcliffe]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Weatherall]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Beasley]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[International Study of Asthma and Allergies in Childhood, An in-verse correlation between estimated tuberculosis noti&#64257;cation rates and asthma symptoms]]></article-title>
<source><![CDATA[Respirology]]></source>
<year>2002</year>
<volume>7</volume>
<page-range>153-5</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ellwood]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Asher]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Bjorksten]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Burr]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pearce]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Robertson]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>2001</year>
<volume>17</volume>
<page-range>436-43</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weiland]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Husing]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Strachan]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Rzehak]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Pearce]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[ISAAC Phase One Study Group, Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children]]></article-title>
<source><![CDATA[Occup Environ Med]]></source>
<year>2004</year>
<volume>61</volume>
<page-range>609-15</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mallol]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Solé]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Asher]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Clayton]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Stein]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Soto Quiroz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prevalence of asthma symptoms in Latin America: the International Study of Asthma and Allergies in Childhood (ISAAC)]]></article-title>
<source><![CDATA[Pediatr Pulmonol]]></source>
<year>2000</year>
<volume>30</volume>
<page-range>439-44</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Solé]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Camelo Nunes]]></surname>
<given-names><![CDATA[IC]]></given-names>
</name>
<name>
<surname><![CDATA[Vanna]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Yamada]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Werneck]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[de Freitas]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prevalence of rhinitis and related-symptoms in schoolchildren from different cities in Brazil]]></article-title>
<source><![CDATA[Allergol Immunopathol (Madr)]]></source>
<year>2004</year>
<volume>32</volume>
<page-range>7-12</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yamada]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vanna]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Naspitz]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Solé]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[International Study of Asthma and Allergies in Childhood (ISAAC): validation of the written questionnaire (eczema component) and prevalence of atopic eczema among Brazilian children]]></article-title>
<source><![CDATA[J Investig Allergol Clin Immunol]]></source>
<year>2002</year>
<volume>12</volume>
<page-range>34-41</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ellwood]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Asher]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Beasley]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Clayton]]></surname>
<given-names><![CDATA[TO]]></given-names>
</name>
<name>
<surname><![CDATA[Stewartt]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[ISAAC Steering Committee. The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods]]></article-title>
<source><![CDATA[Int J Tuberc Lung Dis]]></source>
<year>2005</year>
<volume>9</volume>
<page-range>10-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Solé]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Vanna]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Yamada]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rizzo]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Naspitz]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[International Study of Asthma and Allergies in Childhood (ISAAC) written questionnaire: validation of the asthma component among Brazilian children]]></article-title>
<source><![CDATA[J Invest Allergol Clin Immunol]]></source>
<year>1998</year>
<volume>8</volume>
<page-range>376-82</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vanna]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Yamada]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Arruda]]></surname>
<given-names><![CDATA[LK]]></given-names>
</name>
<name>
<surname><![CDATA[Naspitz]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Sole]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[International Study of Asthma and Allergies in Childhood: validation of the rhinitis symptom questionnaire and prevalence of rhinitis in schoolchildren in São Paulo, Brazil]]></article-title>
<source><![CDATA[Pediatr Allergy Immunol]]></source>
<year>2001</year>
<volume>12</volume>
<page-range>95-101</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<collab>Instituto Brasileiro de Geograa e Estatística</collab>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nnoruka]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Current epidemiology of atopic dermatitis in southeastern Nigeria]]></article-title>
<source><![CDATA[Int J Dermatol]]></source>
<year>2001</year>
<volume>43</volume>
<page-range>739-44</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McNally]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Phillips]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Atopic eczema and the home environment]]></article-title>
<source><![CDATA[Br J Dermatol]]></source>
<year>2001</year>
<volume>145</volume>
<page-range>730-6</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández Mayoralas]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Caballero]]></surname>
<given-names><![CDATA[JMM]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarez]]></surname>
<given-names><![CDATA[LGM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prevalencia de la dermatitis atópica en escolares de Cartagena y su relación con el sexo y la contaminación]]></article-title>
<source><![CDATA[An Pediatr (Barc)]]></source>
<year>2004</year>
<volume>60</volume>
<page-range>555-60</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
